David Mizrahi1, Carolyn Broderick, Michael Friedlander, Mary Ryan, Michelle Harrison, Kate Pumpa, Fiona Naumann. 1. *School of Medical Sciences, University of New South Wales Australia, Sydney, Australia; †Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia; ‡Gynaecological Oncology, Royal Hospital for Women, Sydney, Australia; §Royal Sydney Cancer Centre, Prince Alfred Hospital, Sydney, Australia; ∥Research Institute for Sport and Exercise, University of Canberra, Canberra, Australia; ¶School of Exercise and Nutrition Sciences, Queensland University of Technology, Brisbane, Australia.
Abstract
OBJECTIVE: The aim of this study was to determine the feasibility of a combined supervised and home-based exercise intervention during chemotherapy for women with recurrent ovarian cancer. Secondary aims were to determine the impact of physical activity on physical and psychological outcomes and on chemotherapy completion rates. METHODS:Women with recurrent ovarian cancer were recruited from 3 oncology outpatient clinics in Sydney and Canberra, Australia. All participants received an individualized exercise program that consisted of 90 minutes or more of low to moderate aerobic, resistance, core stability, and balance exercise per week, for 12 weeks. Feasibility was determined by recruitment rate, retention rate, intervention adherence, and adverse events. Aerobic capacity, muscular strength, fatigue, sleep quality, quality of life, depression, and chemotherapy completion rates were assessed at weeks 0, 12, and 24. RESULTS:Thirty participants were recruited (recruitment rate, 63%), with a retention rate of 70%. Participants averaged 196 ± 138 min · wk of low to moderate physical activity throughout the intervention, with adherence to the program at 81%. There were no adverse events resulting from the exercise intervention. Participants who completed the study displayed significant improvements in quality of life (P = 0.017), fatigue (P = 0.004), mental health (P = 0.007), muscular strength (P = 0.001), and balance (P = 0.003) after the intervention. Participants completing the intervention had a higher relative dose intensity than noncompleters (P = 0.03). CONCLUSIONS: A program consisting of low to moderate exercise of 90 min · wk was achieved by two-thirds of women with recurrent ovarian cancer in this study, with no adverse events reported. Randomized control studies are required to confirm the benefits of exercise reported in this study.
RCT Entities:
OBJECTIVE: The aim of this study was to determine the feasibility of a combined supervised and home-based exercise intervention during chemotherapy for women with recurrent ovarian cancer. Secondary aims were to determine the impact of physical activity on physical and psychological outcomes and on chemotherapy completion rates. METHODS:Women with recurrent ovarian cancer were recruited from 3 oncology outpatient clinics in Sydney and Canberra, Australia. All participants received an individualized exercise program that consisted of 90 minutes or more of low to moderate aerobic, resistance, core stability, and balance exercise per week, for 12 weeks. Feasibility was determined by recruitment rate, retention rate, intervention adherence, and adverse events. Aerobic capacity, muscular strength, fatigue, sleep quality, quality of life, depression, and chemotherapy completion rates were assessed at weeks 0, 12, and 24. RESULTS: Thirty participants were recruited (recruitment rate, 63%), with a retention rate of 70%. Participants averaged 196 ± 138 min · wk of low to moderate physical activity throughout the intervention, with adherence to the program at 81%. There were no adverse events resulting from the exercise intervention. Participants who completed the study displayed significant improvements in quality of life (P = 0.017), fatigue (P = 0.004), mental health (P = 0.007), muscular strength (P = 0.001), and balance (P = 0.003) after the intervention. Participants completing the intervention had a higher relative dose intensity than noncompleters (P = 0.03). CONCLUSIONS: A program consisting of low to moderate exercise of 90 min · wk was achieved by two-thirds of women with recurrent ovarian cancer in this study, with no adverse events reported. Randomized control studies are required to confirm the benefits of exercise reported in this study.
Authors: Maria C Swartz; Zakkoyya H Lewis; Elizabeth J Lyons; Kristofer Jennings; Addie Middleton; Rachel R Deer; Demi Arnold; Kaitlin Dresser; Kenneth J Ottenbacher; James S Goodwin Journal: Arch Phys Med Rehabil Date: 2017-04-17 Impact factor: 3.966
Authors: Dorothea Clauss; Christine Tjaden; Thilo Hackert; Lutz Schneider; Cornelia M Ulrich; Joachim Wiskemann; Karen Steindorf Journal: Support Care Cancer Date: 2017-04-17 Impact factor: 3.603
Authors: Bette J Caan; Jeffrey A Meyerhardt; Justin C Brown; Kristin L Campbell; Elizabeth M Cespedes Feliciano; Catherine Lee; Michelle C Ross; Sara Quinney; Charles Quesenberry; Barbara Sternfeld; Kathryn H Schmitz Journal: Contemp Clin Trials Date: 2020-12-07 Impact factor: 2.226
Authors: Mette-Marie Dybeck; Lis Adamsen; Victor Sørensen; Christian Lillelund; Tom Møller; Christina Andersen Journal: Eur J Cancer Care (Engl) Date: 2022-05-12 Impact factor: 2.328
Authors: Stephanie Stelten; Meeke Hoedjes; Gemma G Kenter; Ellen Kampman; Rosalie J Huijsmans; Luc Rcw van Lonkhuijzen; L M Buffart Journal: BMJ Open Date: 2020-11-04 Impact factor: 2.692